JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 37 No. 9 1575-1578
© 1996 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eshima, D.
Right arrow Articles by Taylor, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eshima, D.
Right arrow Articles by Taylor, A. T.

Technetium-99m-Sulfur Colloid for Lymphoscintigraphy: Effects of Preparation Parameters

Dennis Eshima , Lorie A. Eshima, Nancy M. Gotti, Stephen C. Herda, Carrie A. Algozine, Terry G. Burris, John P. Vansant, Naomi P. Alazraki and Andrew T. Taylor

Department of Radiology, Emory University, Atlanta, Georgia
Nuclear Medicine Department, Veterans Administration Hospital, Albuquerque, New Mexico

Correspondence: For correspondence or reprints contact: Dennis Eshima, PhD, Associate Professor of Radiology, Center for Positron Emission Tomography, Emory University, 1364 Clifton Rd. NE, Atlanta, GA 30322.

ABSTRACT

There has been a resurgence in the use of lymphoscintigraphy for the external detection of lymph nodes for metastatic melanoma and breast tumors. Technetium-99m-antimony trisulfide colloid was the radiopharmaceutical developed for this procedure and was found to have a narrow distribution of small particles, 0.003–0.03 µm, but it was never approved by the FDA. Technetium-99m-sulfur colloid also forms particles and this article reports on the effects different preparation parameters have on its particle size distribution and stability. Methods: Four groups of kits were evaluated, kits which utilized: (a) a reduced heating protocol with a new 99mTc-elution, (b) a reduced heating protocol with an old 99mTc-elution, (c) a prolonged heating protocol with a new 99mTc-elution and (d) a prolonged heating protocol with an old 99mTc-elution. The particle size distribution and the stability of the different 99mTc-sulfur colloid kit preparations were evaluated over 6 hr utilizing polycarbonate filters ranging from 0.03 to 10 µm. Results: In vitro studies demonstrated no significant change in the particle size distribution over a 6-hr period and all 99mTc-sulfur colloid preparations had a bimodal particle size distribution pattern. Importantly, heating the kit for shorter periods of times utilizing [99mTc]pertechnetate, which had a longer ingrowth of [99mTc]pertechnetate, produced a formulation which had the largest percentage of particles smaller than 0.03 µm. Conclusion: In our clinical setting, 99mTc-sulfur colloid prepared with the reduced heating protocol and utilizing [99mTc]pertechnetate, which has the highest ingrowth of [99mTc]pertechnetate has proved to be an excellent agent for lymphoscintigraphy studies. This preparation has demonstrated rapid movement of the particles from the primary site to the lymph nodes in over 97% (106/109) of the patients we have studied.

Key Words: technetium-99m-sulfur colloid • lymphoscintigraphy • particle size distribution




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
J. V. Dura and G. H. Hinkle
Stability of a mixture of technetium Tc 99m sulfur colloid and lidocaine hydrochloride
Am. J. Health Syst. Pharm., December 1, 2007; 64(23): 2477 - 2479.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
C. M. Intenzo, S. M. Kim, J. I. Patel, H. C. Lin, and J. C. Kairys
Lymphoscintigraphy in Cutaneous Melanoma: A Total Body Atlas of Sentinel Node Mapping
RadioGraphics, May 1, 2002; 22(3): 491 - 502.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
N. Hodgson, P. Zabel, A.G. Mattar, C.J. Engel, D. Girvan, and R. Holliday
A New Radiocolloid for Sentinel Node Detection in Breast Cancer
Ann. Surg. Oncol., March 1, 2001; 8(2): 133 - 137.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
A. P. Yudd, J. S. Kempf, J. S. Goydos, T. J. Stahl, R. S. Feinstein, and K. G. Baxter
Use of Sentinel Node Lymphoscintigraphy in Malignant Melanoma
RadioGraphics, March 1, 1999; 19(2): 343 - 356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1996 by the Society of Nuclear Medicine.